Print

Cleveland Biolabs Inc. (CBLI) and Incuron Announce Poster Presentation at ESMO 15th World Congress on Gastrointestinal Cancer  
6/25/2013 9:58:42 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BUFFALO, N.Y., June 25, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) and Incuron, LLC, a joint venture between CBLI and Bioprocess Capital Ventures, today announced a poster presentation at the European Society for Medical Oncology (ESMO) 15th World Congress on Gastrointestinal Cancer, July 3-6, 2013 in Barcelona, Spain.

Help employers find you! Check out all the jobs and post your resume.

//-->